{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:05:08Z","timestamp":1792271108563,"version":"4.4.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,12,18]]},"DOI":"10.1001\/jama.2018.18307","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T11:03:10Z","timestamp":1545130990000},"page":"2429","source":"Crossref","is-referenced-by-count":133,"title":["Association of Maternal First-Trimester Ondansetron Use With Cardiac Malformations and Oral Clefts in Offspring"],"prefix":"10.1001","volume":"320","author":[{"given":"Krista F.","family":"Huybrechts","sequence":"first","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Hern\u00e1ndez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreen","family":"Straub","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J.","family":"Gray","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhu","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Patorno","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi J.","family":"Desai","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Mogun","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[{"name":"Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts"},{"name":"Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"joi180140r1","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/AOG.0000000000002456","article-title":"ACOG Practice Bulletin No. 189: Nausea and vomiting of pregnancy.","volume":"131","author":"Committee on Practice Bulletins-Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"5","key":"joi180140r2","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1097\/AOG.0000000000001375","article-title":"Ondansetron use in pregnancy.","volume":"127","author":"Siminerio","year":"2016","journal-title":"Obstet Gynecol"},{"issue":"6","key":"joi180140r3","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1097\/AOG.0000000000000242","article-title":"Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial.","volume":"123","author":"Abas","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"joi180140r4","first-page":"127","article-title":"Ondansetrone or metoclopromide? which is more effective in severe nausea and vomiting of pregnancy? a randomized trial double-blind study.","volume":"40","author":"Kashifard","year":"2013","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"4","key":"joi180140r5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/AOG.0000000000000479","article-title":"Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy: a randomized controlled trial.","volume":"124","author":"Oliveira","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"5","key":"joi180140r6","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/pds.v26.5","article-title":"Antiemetic use among pregnant women in the United States: the escalating use of ondansetron.","volume":"26","author":"Taylor","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"joi180140r7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1056\/NEJMoa1211035","article-title":"Ondansetron in pregnancy and risk of adverse fetal outcomes.","volume":"368","author":"Pasternak","year":"2013","journal-title":"N Engl J Med"},{"key":"joi180140r8","doi-asserted-by":"publisher","first-page":"909860","DOI":"10.1155\/2013\/909860","article-title":"Off-label use of ondansetron in pregnancy in Western Australia.","volume":"2013","author":"Colvin","year":"2013","journal-title":"Biomed Res Int"},{"issue":"9","key":"joi180140r9","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/bjo.2004.111.issue-9","article-title":"The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study.","volume":"111","author":"Einarson","year":"2004","journal-title":"BJOG"},{"issue":"1","key":"joi180140r10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/bdra.22865","article-title":"Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.","volume":"94","author":"Anderka","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"2","key":"joi180140r12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/AOG.0000000000002679","article-title":"Ondansetron for treatment of nausea and vomiting of pregnancy and the risk of specific birth defects.","volume":"132","author":"Parker","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"3","key":"joi180140r13","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1097\/AOG.0000000000001048","article-title":"Practice Bulletin No. 153: Nausea and vomiting of pregnancy.","volume":"126","author":"Practice Bulletin No","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"joi180140r14","doi-asserted-by":"publisher","first-page":"e67405","DOI":"10.1371\/journal.pone.0067405","article-title":"Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations.","volume":"8","author":"Palmsten","year":"2013","journal-title":"PLoS ONE"},{"issue":"25","key":"joi180140r15","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects.","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N Engl J Med"},{"issue":"23","key":"joi180140r16","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","article-title":"Lithium use in pregnancy and the risk of cardiac malformations.","volume":"376","author":"Patorno","year":"2017","journal-title":"N Engl J Med"},{"key":"joi180140r17","doi-asserted-by":"publisher","first-page":"h1035","DOI":"10.1136\/bmj.h1035","article-title":"Statins and congenital malformations: cohort study.","volume":"350","author":"Bateman","year":"2015","journal-title":"BMJ"},{"issue":"21","key":"joi180140r18","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn.","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"joi180140r19","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1097\/AOG.0000000000000982","article-title":"The most commonly dispensed prescription medications among pregnant women enrolled in the US Medicaid program.","volume":"126","author":"Palmsten","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"6","key":"joi180140r20","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/pds.v23.6","article-title":"Validity of maternal and infant outcomes within nationwide Medicaid data.","volume":"23","author":"Palmsten","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"joi180140r21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/(ISSN)1099-1557","article-title":"Positive predictive value of computerized records for major congenital malformations.","volume":"17","author":"Cooper","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"joi180140r23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1097\/AOG.0b013e3182a603bb","article-title":"Development of a comorbidity index for use in obstetric patients.","volume":"122","author":"Bateman","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"9","key":"joi180140r24","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/aje\/154.9.854","article-title":"Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.","volume":"154","author":"Schneeweiss","year":"2001","journal-title":"Am J Epidemiol"},{"issue":"6","key":"joi180140r25","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research.","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"issue":"2","key":"joi180140r26","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1097\/EDE.0000000000000595","article-title":"A propensity-score-based fine stratification approach for confounding adjustment when exposure is infrequent.","volume":"28","author":"Desai","year":"2017","journal-title":"Epidemiology"},{"issue":"4","key":"joi180140r27","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data.","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"1","key":"joi180140r29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00001648-199801000-00004","article-title":"That confounded P-value.","volume":"9","author":"Lang","year":"1998","journal-title":"Epidemiology"},{"issue":"2","key":"joi180140r30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2105\/AJPH.77.2.195","article-title":"Beyond the confidence interval.","volume":"77","author":"Poole","year":"1987","journal-title":"Am J Public Health"},{"key":"joi180140r31","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.reprotox.2014.10.017","article-title":"Use of ondansetron during pregnancy and congenital malformations in the infant.","volume":"50","author":"Danielsson","year":"2014","journal-title":"Reprod Toxicol"},{"issue":"10","key":"joi180140r32","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/pds.v23.10","article-title":"Topiramate use in pregnancy and the birth prevalence of oral clefts.","volume":"23","author":"Mines","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"joi180140r33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2012.153812","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality.","volume":"309","author":"Stephansson","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"joi180140r34","first-page":"e273","article-title":"Medicaid covered births, 2008 through 2010, in the context of the implementation of health reform.","volume":"23","author":"Markus","year":"2013"},{"key":"joi180140r11","article-title":"Ondansetron use in early pregnancy and the risk of congenital malformationsa register based nationwide cohort study.","author":"Andersen","year":"2013"},{"key":"joi180140r28","first-page":"148","volume-title":"Modern Epidemiology","author":"Rothman","year":"2008","edition":"3rd ed"},{"key":"joi180140r22","unstructured":"Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) General Information. https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Computer-Data-and-Systems\/MedicaidDataSourcesGenInfo\/MAXGeneralInformation.html. Accessed November 2017."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2718793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T11:03:17Z","timestamp":1545130997000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.18307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,18]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2018,12,18]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.18307","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12,18]]}}}